References
- HusseinKvan DykeDLTefferiAConventional cytogenetics in myelofibrosis: Literature review and discussionEur J Haematol20098232933819141119
- CervantesFDupriezBPereiraANew prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentBlood20091132895290118988864
- JamesCUgoVLe CouédicJPA unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature20054341144114815793561
- KralovicsRPassamontiFBuserASA gain-of-function mutation of JAK2 in myeloproliferative disordersN Engl J Med20053521779179015858187
- LevineRLWadleighMCoolsJActivating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisCancer Cell2005738739715837627
- BaxterEJScottLMCampbellPJAcquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersLancet20053651054106115781101
- OlcayduDHarutyunyanAJägerRA common JAK2 haplotype confers susceptibility to myeloproliferative neoplasmsNat Genet20094145045419287385
- ScottLMBeerPABenchAJErberWNGreenARPrevalence of JAK2 V617F and exon 12 mutations in polycythaemia veraBr J Haematol200713951151217910642
- LiSKralovicsRde LiberoGTheocharidesAGisslingerHSkodaRCClonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutationsBlood20081113863386618195094
- BeerPACampbellPJScottLMMPL mutations in myeloproliferative disorders: Analysis of the PT-1 cohortBlood200811214114918451306
- ChalignéRJamesCTonettiCEvidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosisBlood20071103735374317709604
- GrandFHHidalgo-CurtisCEErnstTFrequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasmsBlood20091136182619219387008
- CarbucciaNMuratiATrouplinVMutations of ASXL1 gene in myeloproliferative neoplasmsLeukemia2009232183218619609284
- DelhommeauFDupontSDella ValleVMutation in TET2 in myeloid cancersN Engl J Med20093602289230119474426
- SchaubFXLooserRLiSClonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasmsBlood20101152003200720061559
- LangemeijerSMKuiperRPBerendsMAcquired mutations in TET2 are common in myelodysplastic syndromesNat Genet20094183884219483684
- TefferiASkodaRVardimanJWMyeloproliferative neoplasms: Contemporary diagnosis using histology and geneticsNat Rev Clin Oncol2009662763719806146
- JankowskaAMSzpurkaHTiuRVLoss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasmsBlood2009113640710
- KosmiderOGelsi-BoyerVCheokMTET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Blood20091143285329119666869
- KosmiderOGelsi-BoyerVCiudadMTET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemiaHaematologica2009941676168119797729
- TefferiALimKHLevineRMutation in TET2 in myeloid cancersN Engl J Med20093611117 author reply 1117, 1118.19741235
- TefferiAMolecular drug targets in myeloproliferative neoplasms: Mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1J Cell Mol Med20091321523719175693
- Saint-MartinCLeroyGDelhommeauFAnalysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasmsBlood20091141628163219564637
- Abdel-WahabOMullallyAHedvatCGenetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesBlood200911414414719420352
- Abdel-WahabOManshouriTPatelJGenetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemiasCancer Res20107044745220068184
- ViguiéFAbouraABouscaryDCommon 4q24 deletion in four cases of hematopoietic malignancy: Early stem cell involvement?Leukemia2005191411141515920487
- HusseinKAbdel-WahabOLashoTLCytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasmsAm J Hematol201085818319957346
- NajfeldVMontellaLScaliseAFruchtmanSExploring polycythaemia vera with fluorescence in situ hybridization: Additional cryptic 9p is the most frequent abnormality detectedBr J Haematol200211955856612406101
- ShafferLGSlovakMLCampbellLJISCN (2009): International System of Human Cytogenetic NomenclatureBaselS Karger AG2009
- MakishimaHJankowskaAMCazzolliHCbl and TET2 mutations are present in refractory Ph+ disorders including accelerated and blast crisis CML and ALLBlood20091142173